CARM: Carisma Therapeutics Inc Sotuvga nisbatan narx
Carisma Therapeutics (CARM) daromadlarining baholanishi onkoterapiya sohasidagi yetakchilik uchun qizg‘in kurash fonida tebranishlarni namoyish etmoqda, ushbu sektor resurslari boy sog‘liqni saqlash gigantlari tomonidan boshqariladi. Shu bilan birga, 0.60 eng so‘nggi metrika ko‘rsatkichini ifodalab, Carisma Therapeutics (CARM) kompaniyasining tashqi shartnomaviy ishlab chiqarish tashkilotlariga bog‘liqligini ta’kidlaydi. Barqarorlik esa noyob CAR-M platformasi tomonidan ta’minlanadi, u yopiq patent perimetrini yaratadi va klinikalarni uzoq muddatli davolash protokollariga bog‘laydi.
Carisma Tx (CARM) kompaniyasining tahliliy kesimlari
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Barcha qarzlarning o‘z mablag‘lariga nisbati Carisma Therapeutics|CARM - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti Carisma Therapeutics Inc|CARM - Kompaniya qarzlari|Sof aktivlarga qarzlar Carisma Therapeutics|CARM - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli majburiyatlari Carisma Therapeutics|Tezkor likvidlik koeffitsiyenti carismatx.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
CARM - Sof daromad|Kutilayotgan sof daromad Carisma Therapeutics|CARM - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning kelajakdagi foydaga nisbati Carisma Therapeutics Inc.|CARM - PEG multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati CARM|CARM - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Carisma Therapeutics|CARM - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi carismatx.com|CARM - Joriy yilda foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Carisma Therapeutics
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning fundamental tahlili:CARM, Carisma Therapeutics
Carisma Therapeutics (CARM) immunoterapiya ishlab chiqarishini kengaytirish uchun tashqi CDMO inshootlaridan foydalanadi, bu esa kapital xarajatlarini minimallashtiradi. Kompaniyaning joriy P/S koeffitsiyenti umumiy bozor kapitalizatsiyasini olingan daromad bilan solishtirib, sotuvlarning har bir dollari haqiqiy qiymatini ochib beradi. Ushbu grafikdagi narx harakati bozor eyforiyasini fundamental biznes samaradorligi ko'rsatkichlaridan ajratish imkonini beradi. Indikatorlarning ekstremal qiymatlari aktivning kritik darajada qizib ketganini yoki talabning tizimli ravishda pasayganini signalizatsiya qiladi.
Carisma Therapeutics raqobatchilari
argenx - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (biontech.de)|Abivax Corp (ABVX) - Sotuvga nisbatan narx|ADMA Corp - P/S multiplikatori|Narxning sotuvga nisbati PTGX|Immunovant Inc (IMVT) - Narxning daromadga nisbati|KNSA - Narx/daromad koeffitsiyenti|GRFS (Grifols Biemat) - P/S multiplikatori|P/S multiplikatori Adaptive Biotechnologies Inc.|Narxning daromadga nisbati Celldex Therapeutics (CLDX)|Narx/daromad koeffitsiyenti auriniapharma.com|Narxning daromadga nisbati BioCryst Pharmaceuticals BCRX|Bozor kapitallashuvining daromadga nisbati VERA|Dianthus Pharma - P/S multiplikatori|PHVS - P/S multiplikatori|ABCL: P/S multiplikatori|TRML (Tourmaline Bio, Inc.) - Narxning daromadga nisbati|Narxning daromadga nisbati Intrexon|PHAR - Narx/daromad multiplikatori|P/S multiplikatori NKTR|Narxning daromadga nisbati UPB (Upstream Bio Corp)|Narxning daromadga nisbati Zenas Biopharma, Inc. ZBIO|Narx/daromad koeffitsiyenti immunome.com (IMNM)|Gossamer Bio Inc - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati KALV (KalVista Pharmaceuticals, Inc.)|SEPN: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Pieris Pharmaceuticals Inc|Kapitalizatsiyaning daromadga nisbati SVRA|Kapitalizatsiyaning daromadga nisbati Rigel Pharmaceuticals (RIGL)|P/S multiplikatori ANAB|ATXS - Sotuvga nisbatan narx|Narxning daromadga nisbati enGene Corp ENGN|Narx/daromad koeffitsiyenti RAPT Therapeutics, Inc. (RAPT)|Aerovate - P/S multiplikatori|ACRS - P/S multiplikatori|KYTX (Kyverna Therapeutics) - Kapitalizatsiyaning daromadga nisbati|Sotuvga nisbatan narx Tiziana Life Sciences Ltd. (TLSA)|Kapitalizatsiyaning daromadga nisbati CABA|Ventyx Biosciences (VTYX) - Narx/daromad koeffitsiyenti|P/S multiplikatori THTX|AVTX (Avalo Therapeutics, Inc) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ELDN (eledon.com)|AGEN - Kapitalizatsiyaning daromadga nisbati|CLYM - Narxning daromadga nisbati|Narxning sotuvga nisbati ZURA|ATYR: P/S multiplikatori|Adagene Corp (ADAG) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati IMA|Shattuck Labs, Inc. - Narxning sotuvga nisbati|Narxning daromadga nisbati Equillium Inc (EQ)|P/S multiplikatori Connect Biopharma Holdings (CNTB)|Narxning daromadga nisbati Immunic, Inc. IMUX|P/S multiplikatori Atara Biotherapeutics ATRA|IFRX - Narxning daromadga nisbati|XFOR: Narxning daromadga nisbati|ACET: P/S multiplikatori|CELU - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati inmunebio.com|Kapitalizatsiya va daromad nisbati BRNS (barinthusbio.com)|P/S multiplikatori KZR|P/S multiplikatori SAB Biotherapeutics, Inc (SABS)|P/S multiplikatori AKTX (Akari Therapeutics, Plc)|P/S multiplikatori enlivex.com ENLV|QTTB: Kapitalizatsiyaning daromadga nisbati|GOVX - P/S multiplikatori|Edesa Biotech Inc (EDSA) - Narxning daromadga nisbati|IBIO - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati XTLB|Kapitalizatsiyaning daromadga nisbati boltbio.com (BOLT)|Narxning daromadga nisbati HCW Biologics Inc (HCWB)|P/S multiplikatori Aptevo Therapeutics, Inc. (APVO)|Narxning daromadga nisbati aimimmuno.com AIM|Bozor kapitallashuvining daromadga nisbati ADTX|GRI Bio Corporation - P/S multiplikatori|XORTX Corp (XRTX) - Kapitalizatsiyaning daromadga nisbati|HIND (Vyome Holdings Inc.) - Kapitalizatsiyaning daromadga nisbati|revbiosciences.com (REVB) - P/S multiplikatori|INDP (Indaptus Corp) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Scinai Immunotherapeutics Ltd (SCNI)|Narxning daromadga nisbati CalciMedica Inc (CALI)|AFMD (Affimed NV) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ALLK (Allakos Inc.)|P/S multiplikatori HOOKIPA HOOK|IGMS: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ITOS (iTeos)|OCEA: P/S multiplikatori|TCBP (TC BioPharm Ltd) - Narxning daromadga nisbati|THRD (Third Harmonic Bio Inc) - P/S multiplikatori
